nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—Minaprine—Gefitinib—lung cancer	0.596	1	CrCrCtD
Moclobemide—CYP2C19—Gefitinib—lung cancer	0.0301	0.129	CbGbCtD
Moclobemide—CYP2C19—Teniposide—lung cancer	0.0292	0.125	CbGbCtD
Moclobemide—CYP2C9—Gefitinib—lung cancer	0.0251	0.107	CbGbCtD
Moclobemide—CYP2C9—Teniposide—lung cancer	0.0243	0.104	CbGbCtD
Moclobemide—CYP2D6—Gefitinib—lung cancer	0.0229	0.0983	CbGbCtD
Moclobemide—CYP2D6—Vinorelbine—lung cancer	0.0177	0.0757	CbGbCtD
Moclobemide—CYP1A2—Erlotinib—lung cancer	0.0164	0.0705	CbGbCtD
Moclobemide—CYP2C9—Paclitaxel—lung cancer	0.0136	0.0582	CbGbCtD
Moclobemide—CYP2D6—Erlotinib—lung cancer	0.0136	0.0581	CbGbCtD
Moclobemide—CYP1A2—Etoposide—lung cancer	0.0119	0.051	CbGbCtD
Moclobemide—CYP2C9—Cisplatin—lung cancer	0.0109	0.0468	CbGbCtD
Moclobemide—CYP2D6—Vinblastine—lung cancer	0.0109	0.0466	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—lung cancer	0.00669	0.0287	CbGbCtD
Moclobemide—Bezafibrate—CYP1A1—lung cancer	0.000278	0.502	CrCbGaD
Moclobemide—Haloperidol—CYP1A1—lung cancer	0.00018	0.325	CrCbGaD
Moclobemide—Rash—Erlotinib—lung cancer	0.000131	0.00124	CcSEcCtD
Moclobemide—Dermatitis—Erlotinib—lung cancer	0.000131	0.00124	CcSEcCtD
Moclobemide—Palpitations—Paclitaxel—lung cancer	0.000131	0.00124	CcSEcCtD
Moclobemide—Insomnia—Gemcitabine—lung cancer	0.00013	0.00123	CcSEcCtD
Moclobemide—Dyspepsia—Irinotecan—lung cancer	0.00013	0.00123	CcSEcCtD
Moclobemide—Hypertension—Etoposide—lung cancer	0.00013	0.00123	CcSEcCtD
Moclobemide—Headache—Erlotinib—lung cancer	0.00013	0.00123	CcSEcCtD
Moclobemide—Loss of consciousness—Paclitaxel—lung cancer	0.00013	0.00123	CcSEcCtD
Moclobemide—Osteoarthritis—Doxorubicin—lung cancer	0.00013	0.00123	CcSEcCtD
Moclobemide—Hyperhidrosis—Cisplatin—lung cancer	0.00013	0.00123	CcSEcCtD
Moclobemide—Paraesthesia—Gemcitabine—lung cancer	0.000129	0.00123	CcSEcCtD
Moclobemide—Asthenia—Vinorelbine—lung cancer	0.000129	0.00122	CcSEcCtD
Moclobemide—Decreased appetite—Irinotecan—lung cancer	0.000129	0.00122	CcSEcCtD
Moclobemide—Dyspnoea—Gemcitabine—lung cancer	0.000128	0.00122	CcSEcCtD
Moclobemide—Chest pain—Etoposide—lung cancer	0.000128	0.00122	CcSEcCtD
Moclobemide—Nausea—Vinblastine—lung cancer	0.000128	0.00121	CcSEcCtD
Moclobemide—Somnolence—Gemcitabine—lung cancer	0.000128	0.00121	CcSEcCtD
Moclobemide—Migraine—Doxorubicin—lung cancer	0.000128	0.00121	CcSEcCtD
Moclobemide—Hypertension—Paclitaxel—lung cancer	0.000128	0.00121	CcSEcCtD
Moclobemide—Fatigue—Irinotecan—lung cancer	0.000128	0.00121	CcSEcCtD
Moclobemide—Pruritus—Vinorelbine—lung cancer	0.000127	0.0012	CcSEcCtD
Moclobemide—Discomfort—Etoposide—lung cancer	0.000127	0.0012	CcSEcCtD
Moclobemide—Constipation—Irinotecan—lung cancer	0.000126	0.0012	CcSEcCtD
Moclobemide—Chest pain—Paclitaxel—lung cancer	0.000126	0.00119	CcSEcCtD
Moclobemide—Myalgia—Paclitaxel—lung cancer	0.000126	0.00119	CcSEcCtD
Moclobemide—Hypotension—Cisplatin—lung cancer	0.000125	0.00119	CcSEcCtD
Moclobemide—Anxiety—Paclitaxel—lung cancer	0.000125	0.00119	CcSEcCtD
Moclobemide—Decreased appetite—Gemcitabine—lung cancer	0.000125	0.00119	CcSEcCtD
Moclobemide—Nausea—Topotecan—lung cancer	0.000125	0.00118	CcSEcCtD
Moclobemide—Discomfort—Paclitaxel—lung cancer	0.000124	0.00118	CcSEcCtD
Moclobemide—Fatigue—Gemcitabine—lung cancer	0.000124	0.00118	CcSEcCtD
Moclobemide—Confusional state—Etoposide—lung cancer	0.000124	0.00118	CcSEcCtD
Moclobemide—Constipation—Gemcitabine—lung cancer	0.000123	0.00117	CcSEcCtD
Moclobemide—Nausea—Erlotinib—lung cancer	0.000123	0.00117	CcSEcCtD
Moclobemide—Dry mouth—Paclitaxel—lung cancer	0.000123	0.00117	CcSEcCtD
Moclobemide—Diarrhoea—Vinorelbine—lung cancer	0.000123	0.00116	CcSEcCtD
Moclobemide—Dysgeusia—Docetaxel—lung cancer	0.000123	0.00116	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000122	0.00116	CcSEcCtD
Moclobemide—Feeling abnormal—Irinotecan—lung cancer	0.000122	0.00115	CcSEcCtD
Moclobemide—Confusional state—Paclitaxel—lung cancer	0.000122	0.00115	CcSEcCtD
Moclobemide—Dysuria—Methotrexate—lung cancer	0.000121	0.00115	CcSEcCtD
Moclobemide—Gastrointestinal pain—Irinotecan—lung cancer	0.000121	0.00115	CcSEcCtD
Moclobemide—Paraesthesia—Cisplatin—lung cancer	0.000121	0.00114	CcSEcCtD
Moclobemide—Tachycardia—Etoposide—lung cancer	0.00012	0.00114	CcSEcCtD
Moclobemide—Dyspnoea—Cisplatin—lung cancer	0.00012	0.00113	CcSEcCtD
Moclobemide—Dry skin—Doxorubicin—lung cancer	0.000119	0.00113	CcSEcCtD
Moclobemide—Hyperhidrosis—Etoposide—lung cancer	0.000119	0.00113	CcSEcCtD
Moclobemide—Feeling abnormal—Gemcitabine—lung cancer	0.000119	0.00112	CcSEcCtD
Moclobemide—Shock—Paclitaxel—lung cancer	0.000119	0.00112	CcSEcCtD
Moclobemide—Dizziness—Vinorelbine—lung cancer	0.000119	0.00112	CcSEcCtD
Moclobemide—Tachycardia—Paclitaxel—lung cancer	0.000118	0.00112	CcSEcCtD
Moclobemide—Abdominal pain—Irinotecan—lung cancer	0.000117	0.00111	CcSEcCtD
Moclobemide—Decreased appetite—Cisplatin—lung cancer	0.000117	0.00111	CcSEcCtD
Moclobemide—Hyperhidrosis—Paclitaxel—lung cancer	0.000117	0.0011	CcSEcCtD
Moclobemide—Drowsiness—Methotrexate—lung cancer	0.000116	0.00109	CcSEcCtD
Moclobemide—Hypotension—Etoposide—lung cancer	0.000115	0.00109	CcSEcCtD
Moclobemide—Gastritis—Doxorubicin—lung cancer	0.000115	0.00109	CcSEcCtD
Moclobemide—Vomiting—Vinorelbine—lung cancer	0.000114	0.00108	CcSEcCtD
Moclobemide—Rash—Vinorelbine—lung cancer	0.000113	0.00107	CcSEcCtD
Moclobemide—Dermatitis—Vinorelbine—lung cancer	0.000113	0.00107	CcSEcCtD
Moclobemide—Abdominal distension—Doxorubicin—lung cancer	0.000113	0.00107	CcSEcCtD
Moclobemide—Hypotension—Paclitaxel—lung cancer	0.000113	0.00107	CcSEcCtD
Moclobemide—Stomatitis—Methotrexate—lung cancer	0.000113	0.00107	CcSEcCtD
Moclobemide—Headache—Vinorelbine—lung cancer	0.000112	0.00106	CcSEcCtD
Moclobemide—Syncope—Docetaxel—lung cancer	0.000112	0.00106	CcSEcCtD
Moclobemide—Conjunctivitis—Methotrexate—lung cancer	0.000112	0.00106	CcSEcCtD
Moclobemide—Sweating—Methotrexate—lung cancer	0.000111	0.00105	CcSEcCtD
Moclobemide—Palpitations—Docetaxel—lung cancer	0.000111	0.00105	CcSEcCtD
Moclobemide—Feeling abnormal—Cisplatin—lung cancer	0.000111	0.00105	CcSEcCtD
Moclobemide—Paraesthesia—Etoposide—lung cancer	0.00011	0.00105	CcSEcCtD
Moclobemide—Loss of consciousness—Docetaxel—lung cancer	0.00011	0.00104	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00011	0.00104	CcSEcCtD
Moclobemide—Dyspnoea—Etoposide—lung cancer	0.00011	0.00104	CcSEcCtD
Moclobemide—Somnolence—Etoposide—lung cancer	0.000109	0.00104	CcSEcCtD
Moclobemide—Angina pectoris—Doxorubicin—lung cancer	0.000109	0.00104	CcSEcCtD
Moclobemide—Insomnia—Paclitaxel—lung cancer	0.000109	0.00103	CcSEcCtD
Moclobemide—Paraesthesia—Paclitaxel—lung cancer	0.000108	0.00103	CcSEcCtD
Moclobemide—Hypertension—Docetaxel—lung cancer	0.000108	0.00102	CcSEcCtD
Moclobemide—Dyspnoea—Paclitaxel—lung cancer	0.000108	0.00102	CcSEcCtD
Moclobemide—Somnolence—Paclitaxel—lung cancer	0.000107	0.00102	CcSEcCtD
Moclobemide—Decreased appetite—Etoposide—lung cancer	0.000107	0.00101	CcSEcCtD
Moclobemide—Chest pain—Docetaxel—lung cancer	0.000107	0.00101	CcSEcCtD
Moclobemide—Myalgia—Docetaxel—lung cancer	0.000107	0.00101	CcSEcCtD
Moclobemide—Nausea—Vinorelbine—lung cancer	0.000107	0.00101	CcSEcCtD
Moclobemide—Dyspepsia—Paclitaxel—lung cancer	0.000106	0.00101	CcSEcCtD
Moclobemide—Asthenia—Irinotecan—lung cancer	0.000106	0.00101	CcSEcCtD
Moclobemide—Fatigue—Etoposide—lung cancer	0.000106	0.001	CcSEcCtD
Moclobemide—Constipation—Etoposide—lung cancer	0.000105	0.000997	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—lung cancer	0.000105	0.000994	CcSEcCtD
Moclobemide—Decreased appetite—Paclitaxel—lung cancer	0.000105	0.000993	CcSEcCtD
Moclobemide—Dry mouth—Docetaxel—lung cancer	0.000104	0.000988	CcSEcCtD
Moclobemide—Fatigue—Paclitaxel—lung cancer	0.000104	0.000985	CcSEcCtD
Moclobemide—Asthenia—Gemcitabine—lung cancer	0.000103	0.000979	CcSEcCtD
Moclobemide—Constipation—Paclitaxel—lung cancer	0.000103	0.000977	CcSEcCtD
Moclobemide—Confusional state—Docetaxel—lung cancer	0.000103	0.000977	CcSEcCtD
Moclobemide—Pruritus—Gemcitabine—lung cancer	0.000102	0.000966	CcSEcCtD
Moclobemide—Feeling abnormal—Etoposide—lung cancer	0.000101	0.00096	CcSEcCtD
Moclobemide—Diarrhoea—Irinotecan—lung cancer	0.000101	0.000959	CcSEcCtD
Moclobemide—Gastrointestinal pain—Etoposide—lung cancer	0.000101	0.000953	CcSEcCtD
Moclobemide—Shock—Docetaxel—lung cancer	0.000101	0.000953	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—lung cancer	0.0001	0.000948	CcSEcCtD
Moclobemide—Visual impairment—Methotrexate—lung cancer	0.0001	0.000947	CcSEcCtD
Moclobemide—Tachycardia—Docetaxel—lung cancer	9.98e-05	0.000945	CcSEcCtD
Moclobemide—Feeling abnormal—Paclitaxel—lung cancer	9.94e-05	0.000942	CcSEcCtD
Moclobemide—Gastrointestinal pain—Paclitaxel—lung cancer	9.86e-05	0.000934	CcSEcCtD
Moclobemide—Diarrhoea—Gemcitabine—lung cancer	9.86e-05	0.000934	CcSEcCtD
Moclobemide—Dizziness—Irinotecan—lung cancer	9.78e-05	0.000927	CcSEcCtD
Moclobemide—Urticaria—Etoposide—lung cancer	9.77e-05	0.000926	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—lung cancer	9.75e-05	0.000924	CcSEcCtD
Moclobemide—Abdominal pain—Etoposide—lung cancer	9.73e-05	0.000921	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—lung cancer	9.73e-05	0.000921	CcSEcCtD
Moclobemide—Tinnitus—Methotrexate—lung cancer	9.67e-05	0.000916	CcSEcCtD
Moclobemide—Asthenia—Cisplatin—lung cancer	9.64e-05	0.000913	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—lung cancer	9.59e-05	0.000909	CcSEcCtD
Moclobemide—Urticaria—Paclitaxel—lung cancer	9.58e-05	0.000908	CcSEcCtD
Moclobemide—Haloperidol—ABCB1—lung cancer	9.57e-05	0.173	CrCbGaD
Moclobemide—Hypotension—Docetaxel—lung cancer	9.55e-05	0.000905	CcSEcCtD
Moclobemide—Abdominal pain—Paclitaxel—lung cancer	9.54e-05	0.000903	CcSEcCtD
Moclobemide—Vomiting—Irinotecan—lung cancer	9.4e-05	0.000891	CcSEcCtD
Moclobemide—Rash—Irinotecan—lung cancer	9.33e-05	0.000883	CcSEcCtD
Moclobemide—Dermatitis—Irinotecan—lung cancer	9.32e-05	0.000883	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Docetaxel—lung cancer	9.32e-05	0.000882	CcSEcCtD
Moclobemide—Headache—Irinotecan—lung cancer	9.27e-05	0.000878	CcSEcCtD
Moclobemide—Insomnia—Docetaxel—lung cancer	9.25e-05	0.000876	CcSEcCtD
Moclobemide—Diarrhoea—Cisplatin—lung cancer	9.19e-05	0.00087	CcSEcCtD
Moclobemide—Paraesthesia—Docetaxel—lung cancer	9.18e-05	0.00087	CcSEcCtD
Moclobemide—Vomiting—Gemcitabine—lung cancer	9.16e-05	0.000868	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—lung cancer	9.14e-05	0.000866	CcSEcCtD
Moclobemide—Dyspnoea—Docetaxel—lung cancer	9.12e-05	0.000863	CcSEcCtD
Moclobemide—Somnolence—Docetaxel—lung cancer	9.09e-05	0.000861	CcSEcCtD
Moclobemide—Rash—Gemcitabine—lung cancer	9.08e-05	0.000861	CcSEcCtD
Moclobemide—Dermatitis—Gemcitabine—lung cancer	9.08e-05	0.00086	CcSEcCtD
Moclobemide—Headache—Gemcitabine—lung cancer	9.03e-05	0.000855	CcSEcCtD
Moclobemide—Dyspepsia—Docetaxel—lung cancer	9e-05	0.000853	CcSEcCtD
Moclobemide—Decreased appetite—Docetaxel—lung cancer	8.89e-05	0.000842	CcSEcCtD
Moclobemide—Dysgeusia—Methotrexate—lung cancer	8.84e-05	0.000838	CcSEcCtD
Moclobemide—Asthenia—Etoposide—lung cancer	8.83e-05	0.000836	CcSEcCtD
Moclobemide—Fatigue—Docetaxel—lung cancer	8.82e-05	0.000835	CcSEcCtD
Moclobemide—Nausea—Irinotecan—lung cancer	8.79e-05	0.000832	CcSEcCtD
Moclobemide—Constipation—Docetaxel—lung cancer	8.74e-05	0.000828	CcSEcCtD
Moclobemide—Pruritus—Etoposide—lung cancer	8.7e-05	0.000825	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—lung cancer	8.66e-05	0.00082	CcSEcCtD
Moclobemide—Asthenia—Paclitaxel—lung cancer	8.65e-05	0.00082	CcSEcCtD
Moclobemide—Nausea—Gemcitabine—lung cancer	8.56e-05	0.000811	CcSEcCtD
Moclobemide—Vomiting—Cisplatin—lung cancer	8.54e-05	0.000809	CcSEcCtD
Moclobemide—Pruritus—Paclitaxel—lung cancer	8.53e-05	0.000808	CcSEcCtD
Moclobemide—Vision blurred—Methotrexate—lung cancer	8.51e-05	0.000806	CcSEcCtD
Moclobemide—Rash—Cisplatin—lung cancer	8.47e-05	0.000802	CcSEcCtD
Moclobemide—Dermatitis—Cisplatin—lung cancer	8.46e-05	0.000801	CcSEcCtD
Moclobemide—Feeling abnormal—Docetaxel—lung cancer	8.43e-05	0.000798	CcSEcCtD
Moclobemide—Diarrhoea—Etoposide—lung cancer	8.42e-05	0.000797	CcSEcCtD
Moclobemide—Ill-defined disorder—Methotrexate—lung cancer	8.38e-05	0.000794	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—lung cancer	8.37e-05	0.000793	CcSEcCtD
Moclobemide—Gastrointestinal pain—Docetaxel—lung cancer	8.36e-05	0.000792	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—lung cancer	8.34e-05	0.00079	CcSEcCtD
Moclobemide—Diarrhoea—Paclitaxel—lung cancer	8.25e-05	0.000782	CcSEcCtD
Moclobemide—Malaise—Methotrexate—lung cancer	8.14e-05	0.000771	CcSEcCtD
Moclobemide—Dizziness—Etoposide—lung cancer	8.14e-05	0.000771	CcSEcCtD
Moclobemide—Abdominal pain—Docetaxel—lung cancer	8.08e-05	0.000766	CcSEcCtD
Moclobemide—Dizziness—Paclitaxel—lung cancer	7.98e-05	0.000756	CcSEcCtD
Moclobemide—Nausea—Cisplatin—lung cancer	7.98e-05	0.000756	CcSEcCtD
Moclobemide—Vomiting—Etoposide—lung cancer	7.82e-05	0.000741	CcSEcCtD
Moclobemide—Rash—Etoposide—lung cancer	7.76e-05	0.000735	CcSEcCtD
Moclobemide—Dermatitis—Etoposide—lung cancer	7.75e-05	0.000734	CcSEcCtD
Moclobemide—Headache—Etoposide—lung cancer	7.71e-05	0.00073	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—lung cancer	7.7e-05	0.00073	CcSEcCtD
Moclobemide—Chest pain—Methotrexate—lung cancer	7.69e-05	0.000728	CcSEcCtD
Moclobemide—Myalgia—Methotrexate—lung cancer	7.69e-05	0.000728	CcSEcCtD
Moclobemide—Tension—Doxorubicin—lung cancer	7.67e-05	0.000727	CcSEcCtD
Moclobemide—Vomiting—Paclitaxel—lung cancer	7.67e-05	0.000727	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—lung cancer	7.66e-05	0.000725	CcSEcCtD
Moclobemide—Rash—Paclitaxel—lung cancer	7.61e-05	0.00072	CcSEcCtD
Moclobemide—Dermatitis—Paclitaxel—lung cancer	7.6e-05	0.00072	CcSEcCtD
Moclobemide—Discomfort—Methotrexate—lung cancer	7.6e-05	0.000719	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—lung cancer	7.59e-05	0.000719	CcSEcCtD
Moclobemide—Headache—Paclitaxel—lung cancer	7.56e-05	0.000716	CcSEcCtD
Moclobemide—Confusional state—Methotrexate—lung cancer	7.43e-05	0.000704	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—lung cancer	7.37e-05	0.000698	CcSEcCtD
Moclobemide—Asthenia—Docetaxel—lung cancer	7.34e-05	0.000695	CcSEcCtD
Moclobemide—Nausea—Etoposide—lung cancer	7.31e-05	0.000692	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—lung cancer	7.25e-05	0.000687	CcSEcCtD
Moclobemide—Pruritus—Docetaxel—lung cancer	7.23e-05	0.000685	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—lung cancer	7.19e-05	0.000681	CcSEcCtD
Moclobemide—Nausea—Paclitaxel—lung cancer	7.17e-05	0.000679	CcSEcCtD
Moclobemide—Hyperhidrosis—Methotrexate—lung cancer	7.12e-05	0.000675	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—lung cancer	7.05e-05	0.000668	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—lung cancer	7.01e-05	0.000664	CcSEcCtD
Moclobemide—Diarrhoea—Docetaxel—lung cancer	7e-05	0.000663	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—lung cancer	6.91e-05	0.000655	CcSEcCtD
Moclobemide—Hypotension—Methotrexate—lung cancer	6.89e-05	0.000652	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—lung cancer	6.87e-05	0.000651	CcSEcCtD
Moclobemide—Dizziness—Docetaxel—lung cancer	6.76e-05	0.00064	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—lung cancer	6.75e-05	0.000639	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Methotrexate—lung cancer	6.71e-05	0.000636	CcSEcCtD
Moclobemide—Insomnia—Methotrexate—lung cancer	6.67e-05	0.000631	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—lung cancer	6.66e-05	0.000631	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—lung cancer	6.66e-05	0.000631	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—lung cancer	6.63e-05	0.000628	CcSEcCtD
Moclobemide—Paraesthesia—Methotrexate—lung cancer	6.62e-05	0.000627	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—lung cancer	6.58e-05	0.000623	CcSEcCtD
Moclobemide—Dyspnoea—Methotrexate—lung cancer	6.57e-05	0.000622	CcSEcCtD
Moclobemide—Somnolence—Methotrexate—lung cancer	6.55e-05	0.000621	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—lung cancer	6.51e-05	0.000617	CcSEcCtD
Moclobemide—Vomiting—Docetaxel—lung cancer	6.5e-05	0.000616	CcSEcCtD
Moclobemide—Dyspepsia—Methotrexate—lung cancer	6.49e-05	0.000614	CcSEcCtD
Moclobemide—Rash—Docetaxel—lung cancer	6.45e-05	0.000611	CcSEcCtD
Moclobemide—Dermatitis—Docetaxel—lung cancer	6.44e-05	0.00061	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—lung cancer	6.43e-05	0.000609	CcSEcCtD
Moclobemide—Decreased appetite—Methotrexate—lung cancer	6.41e-05	0.000607	CcSEcCtD
Moclobemide—Headache—Docetaxel—lung cancer	6.41e-05	0.000607	CcSEcCtD
Moclobemide—Fatigue—Methotrexate—lung cancer	6.35e-05	0.000602	CcSEcCtD
Moclobemide—Shock—Doxorubicin—lung cancer	6.28e-05	0.000595	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—lung cancer	6.23e-05	0.00059	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—lung cancer	6.17e-05	0.000584	CcSEcCtD
Moclobemide—Nausea—Docetaxel—lung cancer	6.07e-05	0.000575	CcSEcCtD
Moclobemide—Feeling abnormal—Methotrexate—lung cancer	6.07e-05	0.000575	CcSEcCtD
Moclobemide—Gastrointestinal pain—Methotrexate—lung cancer	6.03e-05	0.000571	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—lung cancer	5.96e-05	0.000565	CcSEcCtD
Moclobemide—Urticaria—Methotrexate—lung cancer	5.85e-05	0.000555	CcSEcCtD
Moclobemide—Abdominal pain—Methotrexate—lung cancer	5.83e-05	0.000552	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.81e-05	0.000551	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—lung cancer	5.77e-05	0.000547	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—lung cancer	5.73e-05	0.000543	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—lung cancer	5.69e-05	0.000539	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—lung cancer	5.67e-05	0.000537	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—lung cancer	5.62e-05	0.000532	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—lung cancer	5.55e-05	0.000525	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—lung cancer	5.5e-05	0.000521	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—lung cancer	5.46e-05	0.000517	CcSEcCtD
Moclobemide—Asthenia—Methotrexate—lung cancer	5.29e-05	0.000501	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—lung cancer	5.26e-05	0.000498	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—lung cancer	5.22e-05	0.000494	CcSEcCtD
Moclobemide—Pruritus—Methotrexate—lung cancer	5.21e-05	0.000494	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—lung cancer	5.07e-05	0.00048	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—lung cancer	5.04e-05	0.000478	CcSEcCtD
Moclobemide—Diarrhoea—Methotrexate—lung cancer	5.04e-05	0.000478	CcSEcCtD
Moclobemide—Dizziness—Methotrexate—lung cancer	4.87e-05	0.000462	CcSEcCtD
Moclobemide—Vomiting—Methotrexate—lung cancer	4.69e-05	0.000444	CcSEcCtD
Moclobemide—Rash—Methotrexate—lung cancer	4.65e-05	0.00044	CcSEcCtD
Moclobemide—Dermatitis—Methotrexate—lung cancer	4.64e-05	0.00044	CcSEcCtD
Moclobemide—Headache—Methotrexate—lung cancer	4.62e-05	0.000437	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—lung cancer	4.58e-05	0.000434	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—lung cancer	4.51e-05	0.000428	CcSEcCtD
Moclobemide—Nausea—Methotrexate—lung cancer	4.38e-05	0.000415	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—lung cancer	4.37e-05	0.000414	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—lung cancer	4.22e-05	0.0004	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—lung cancer	4.06e-05	0.000384	CcSEcCtD
Moclobemide—Rash—Doxorubicin—lung cancer	4.02e-05	0.000381	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—lung cancer	4.02e-05	0.000381	CcSEcCtD
Moclobemide—Headache—Doxorubicin—lung cancer	4e-05	0.000379	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—lung cancer	3.79e-05	0.000359	CcSEcCtD
Moclobemide—MAOB—Metabolism—PIK3CG—lung cancer	1.41e-05	0.000217	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—STK11—lung cancer	1.4e-05	0.000216	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2A7—lung cancer	1.39e-05	0.000213	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CKB—lung cancer	1.38e-05	0.000213	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2A7—lung cancer	1.38e-05	0.000212	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—SDC4—lung cancer	1.36e-05	0.000209	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—SDC4—lung cancer	1.35e-05	0.000207	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—RRM1—lung cancer	1.35e-05	0.000207	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTA3—lung cancer	1.35e-05	0.000207	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—POMC—lung cancer	1.35e-05	0.000207	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CREBBP—lung cancer	1.31e-05	0.000201	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CNDP2—lung cancer	1.3e-05	0.0002	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTM2—lung cancer	1.3e-05	0.0002	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTP1—lung cancer	1.3e-05	0.0002	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTMR3—lung cancer	1.27e-05	0.000194	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—B4GALT5—lung cancer	1.27e-05	0.000194	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CAT—lung cancer	1.26e-05	0.000194	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CD—lung cancer	1.24e-05	0.000191	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—RRM1—lung cancer	1.24e-05	0.00019	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTA3—lung cancer	1.24e-05	0.00019	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PGAM1—lung cancer	1.23e-05	0.000189	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTA4—lung cancer	1.23e-05	0.000189	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ABCB1—lung cancer	1.23e-05	0.000189	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—RRM1—lung cancer	1.23e-05	0.000189	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTA3—lung cancer	1.23e-05	0.000189	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ALB—lung cancer	1.23e-05	0.000188	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—TYMS—lung cancer	1.21e-05	0.000186	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.2e-05	0.000185	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTA2—lung cancer	1.2e-05	0.000184	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTM1—lung cancer	1.19e-05	0.000183	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2A7—lung cancer	1.18e-05	0.000181	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—B4GALT5—lung cancer	1.16e-05	0.000179	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTA1—lung cancer	1.16e-05	0.000178	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—B4GALT5—lung cancer	1.15e-05	0.000177	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—SDC4—lung cancer	1.15e-05	0.000177	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCC3—lung cancer	1.14e-05	0.000176	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTA4—lung cancer	1.13e-05	0.000174	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP1A1—lung cancer	1.13e-05	0.000174	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ERCC2—lung cancer	1.12e-05	0.000172	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTA4—lung cancer	1.12e-05	0.000172	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKR1C1—lung cancer	1.11e-05	0.00017	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTA2—lung cancer	1.1e-05	0.00017	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.1e-05	0.000169	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTA2—lung cancer	1.09e-05	0.000168	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CB—lung cancer	1.08e-05	0.000166	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—UGT1A1—lung cancer	1.08e-05	0.000165	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTGS2—lung cancer	1.07e-05	0.000165	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTA1—lung cancer	1.06e-05	0.000164	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTA1—lung cancer	1.06e-05	0.000162	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCC3—lung cancer	1.05e-05	0.000162	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—RRM1—lung cancer	1.05e-05	0.000161	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA3—lung cancer	1.05e-05	0.000161	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCC3—lung cancer	1.04e-05	0.00016	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GNG11—lung cancer	1.04e-05	0.000159	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.03e-05	0.000159	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKR1C1—lung cancer	1.02e-05	0.000157	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKR1C1—lung cancer	1.01e-05	0.000155	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—UGT1A1—lung cancer	9.9e-06	0.000152	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALDOA—lung cancer	9.88e-06	0.000152	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—B4GALT5—lung cancer	9.86e-06	0.000151	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—UGT1A1—lung cancer	9.81e-06	0.000151	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—APOA1—lung cancer	9.71e-06	0.000149	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA4—lung cancer	9.59e-06	0.000147	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NCOA3—lung cancer	9.59e-06	0.000147	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GNG11—lung cancer	9.54e-06	0.000147	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GNG11—lung cancer	9.46e-06	0.000145	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.42e-06	0.000145	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	9.41e-06	0.000145	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	9.38e-06	0.000144	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PTEN—lung cancer	9.36e-06	0.000144	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA2—lung cancer	9.35e-06	0.000144	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ADCY1—lung cancer	9.33e-06	0.000143	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCG2—lung cancer	9.33e-06	0.000143	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ENO2—lung cancer	9.15e-06	0.000141	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HPGDS—lung cancer	9.15e-06	0.000141	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPP2R1B—lung cancer	9.09e-06	0.00014	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALDOA—lung cancer	9.09e-06	0.00014	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA1—lung cancer	9.02e-06	0.000139	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALDOA—lung cancer	9.01e-06	0.000138	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.97e-06	0.000138	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—EP300—lung cancer	8.92e-06	0.000137	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCC3—lung cancer	8.92e-06	0.000137	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTT1—lung cancer	8.87e-06	0.000136	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CG—lung cancer	8.87e-06	0.000136	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NCOA3—lung cancer	8.82e-06	0.000136	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2A6—lung cancer	8.77e-06	0.000135	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GCLC—lung cancer	8.77e-06	0.000135	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NCOA3—lung cancer	8.75e-06	0.000134	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.74e-06	0.000134	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKR1C1—lung cancer	8.64e-06	0.000133	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	8.59e-06	0.000132	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCG2—lung cancer	8.58e-06	0.000132	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ADCY1—lung cancer	8.58e-06	0.000132	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCG2—lung cancer	8.51e-06	0.000131	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ADCY1—lung cancer	8.51e-06	0.000131	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—POMC—lung cancer	8.44e-06	0.00013	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ENO2—lung cancer	8.42e-06	0.000129	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HPGDS—lung cancer	8.42e-06	0.000129	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—UGT1A1—lung cancer	8.38e-06	0.000129	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPP2R1B—lung cancer	8.36e-06	0.000128	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HPGDS—lung cancer	8.34e-06	0.000128	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ENO2—lung cancer	8.34e-06	0.000128	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ENO1—lung cancer	8.32e-06	0.000128	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPP2R1B—lung cancer	8.29e-06	0.000127	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.29e-06	0.000127	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CREBBP—lung cancer	8.22e-06	0.000126	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	8.18e-06	0.000126	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.18e-06	0.000126	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTT1—lung cancer	8.16e-06	0.000125	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTT1—lung cancer	8.09e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GNG11—lung cancer	8.08e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GCLC—lung cancer	8.07e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2A6—lung cancer	8.07e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	8.04e-06	0.000124	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2A6—lung cancer	8e-06	0.000123	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GCLC—lung cancer	8e-06	0.000123	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	7.97e-06	0.000122	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CD—lung cancer	7.8e-06	0.00012	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALDOA—lung cancer	7.7e-06	0.000118	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALB—lung cancer	7.7e-06	0.000118	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ENO1—lung cancer	7.65e-06	0.000117	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ENO1—lung cancer	7.58e-06	0.000116	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.55e-06	0.000116	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NCOA3—lung cancer	7.47e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2E1—lung cancer	7.46e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.46e-06	0.000115	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NQO1—lung cancer	7.38e-06	0.000113	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	7.34e-06	0.000113	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCG2—lung cancer	7.27e-06	0.000112	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ADCY1—lung cancer	7.27e-06	0.000112	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.22e-06	0.000111	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.16e-06	0.00011	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ENO2—lung cancer	7.13e-06	0.00011	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HPGDS—lung cancer	7.13e-06	0.00011	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPP2R1B—lung cancer	7.08e-06	0.000109	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	6.99e-06	0.000107	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTT1—lung cancer	6.91e-06	0.000106	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2E1—lung cancer	6.86e-06	0.000105	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2A6—lung cancer	6.83e-06	0.000105	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GCLC—lung cancer	6.83e-06	0.000105	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	6.81e-06	0.000105	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2E1—lung cancer	6.8e-06	0.000104	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CB—lung cancer	6.79e-06	0.000104	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NQO1—lung cancer	6.78e-06	0.000104	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTGS2—lung cancer	6.73e-06	0.000103	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NQO1—lung cancer	6.72e-06	0.000103	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—STK11—lung cancer	6.65e-06	0.000102	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CA—lung cancer	6.6e-06	0.000101	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.58e-06	0.000101	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.52e-06	0.0001	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ENO1—lung cancer	6.48e-06	9.95e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	6.46e-06	9.92e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	6.37e-06	9.79e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.24e-06	9.59e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTP1—lung cancer	6.15e-06	9.45e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—STK11—lung cancer	6.11e-06	9.39e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—STK11—lung cancer	6.06e-06	9.31e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CAT—lung cancer	5.99e-06	9.19e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.95e-06	9.14e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PTEN—lung cancer	5.87e-06	9.02e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ABCB1—lung cancer	5.82e-06	8.94e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2E1—lung cancer	5.81e-06	8.93e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NQO1—lung cancer	5.75e-06	8.83e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TYMS—lung cancer	5.72e-06	8.78e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.69e-06	8.74e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTP1—lung cancer	5.66e-06	8.69e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTM1—lung cancer	5.65e-06	8.68e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.63e-06	8.64e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTP1—lung cancer	5.61e-06	8.62e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—EP300—lung cancer	5.6e-06	8.6e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.58e-06	8.56e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CAT—lung cancer	5.51e-06	8.46e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CAT—lung cancer	5.46e-06	8.38e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.43e-06	8.34e-05	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—lung cancer	5.39e-06	8.28e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1A1—lung cancer	5.36e-06	8.23e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ABCB1—lung cancer	5.36e-06	8.23e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ERCC2—lung cancer	5.31e-06	8.16e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ABCB1—lung cancer	5.31e-06	8.16e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TYMS—lung cancer	5.26e-06	8.08e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TYMS—lung cancer	5.21e-06	8.01e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTM1—lung cancer	5.2e-06	7.99e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—STK11—lung cancer	5.18e-06	7.96e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTM1—lung cancer	5.15e-06	7.92e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1A1—lung cancer	4.93e-06	7.57e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ERCC2—lung cancer	4.89e-06	7.51e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1A1—lung cancer	4.89e-06	7.51e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.86e-06	7.47e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ERCC2—lung cancer	4.85e-06	7.44e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTP1—lung cancer	4.79e-06	7.36e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CAT—lung cancer	4.66e-06	7.16e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.64e-06	7.12e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—APOA1—lung cancer	4.6e-06	7.06e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ABCB1—lung cancer	4.54e-06	6.97e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TYMS—lung cancer	4.46e-06	6.84e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTM1—lung cancer	4.4e-06	6.77e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.4e-06	6.76e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—APOA1—lung cancer	4.23e-06	6.5e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CG—lung cancer	4.2e-06	6.45e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—APOA1—lung cancer	4.19e-06	6.44e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1A1—lung cancer	4.18e-06	6.41e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CA—lung cancer	4.14e-06	6.36e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ERCC2—lung cancer	4.14e-06	6.36e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.01e-06	6.17e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—POMC—lung cancer	4e-06	6.14e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CREBBP—lung cancer	3.89e-06	5.98e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CG—lung cancer	3.86e-06	5.93e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CG—lung cancer	3.83e-06	5.88e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CD—lung cancer	3.69e-06	5.67e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—POMC—lung cancer	3.67e-06	5.64e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—POMC—lung cancer	3.64e-06	5.6e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALB—lung cancer	3.64e-06	5.6e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—APOA1—lung cancer	3.58e-06	5.5e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CREBBP—lung cancer	3.58e-06	5.5e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CREBBP—lung cancer	3.55e-06	5.45e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.43e-06	5.27e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CD—lung cancer	3.39e-06	5.21e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—lung cancer	3.38e-06	5.2e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CD—lung cancer	3.36e-06	5.17e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALB—lung cancer	3.35e-06	5.15e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALB—lung cancer	3.32e-06	5.1e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CG—lung cancer	3.27e-06	5.02e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CB—lung cancer	3.22e-06	4.94e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTGS2—lung cancer	3.19e-06	4.9e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—POMC—lung cancer	3.11e-06	4.78e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CREBBP—lung cancer	3.03e-06	4.66e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CB—lung cancer	2.96e-06	4.54e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CB—lung cancer	2.93e-06	4.5e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTGS2—lung cancer	2.93e-06	4.5e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTGS2—lung cancer	2.91e-06	4.46e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CD—lung cancer	2.88e-06	4.42e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALB—lung cancer	2.84e-06	4.36e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PTEN—lung cancer	2.78e-06	4.27e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—EP300—lung cancer	2.65e-06	4.07e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PTEN—lung cancer	2.56e-06	3.93e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PTEN—lung cancer	2.53e-06	3.89e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CB—lung cancer	2.51e-06	3.85e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTGS2—lung cancer	2.48e-06	3.81e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—EP300—lung cancer	2.44e-06	3.74e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—EP300—lung cancer	2.42e-06	3.71e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PTEN—lung cancer	2.17e-06	3.33e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—EP300—lung cancer	2.07e-06	3.17e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CA—lung cancer	1.96e-06	3.01e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CA—lung cancer	1.8e-06	2.77e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CA—lung cancer	1.79e-06	2.75e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—lung cancer	1.6e-06	2.46e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CA—lung cancer	1.53e-06	2.35e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—lung cancer	1.47e-06	2.26e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—lung cancer	1.46e-06	2.24e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—lung cancer	1.25e-06	1.92e-05	CbGpPWpGaD
